title: [18F-FDG PET/CT in staging and restaging cholangiocarcinoma].
abstract: The prognosis for hepatobiliary malignancies is dismal. Surgery remains the primary curative option. The positron emission tomography/computed tomography (PET/CT) provides simultaneous metabolic and anatomic information on tumors in the same imaging session. The role of PET/CT in detecting hepatobiliary malignancies has not yet been established. The purpose of this review was to examine the literature on the use of PET/CT in cholangiocarcinomas, also in order to improve the preoperative staging and the restaging, for a proper oncology management of patients.
authors.forename: Antonio
authors.initials: A
authors.lastname: Notaristefano
authors.forename: Artor
authors.initials: A
authors.lastname: Niccoli Asabella
authors.forename: Amato Antonio
authors.initials: AA
authors.lastname: Stabile Ianora
authors.forename: Nunzio
authors.initials: N
authors.lastname: Merenda
authors.forename: Marco
authors.initials: M
authors.lastname: Moschetta
authors.forename: Filippo
authors.initials: F
authors.lastname: Antonica
authors.forename: Corinna
authors.initials: C
authors.lastname: Altini
authors.forename: Cristina
authors.initials: C
authors.lastname: Ferrari
authors.forename: Elviro
authors.initials: E
authors.lastname: Cesarano
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Rubini
mesh_terms: D016477:Artifacts; D001650:Bile Duct Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D001653:Bile Ducts, Intrahepatic / Q000000981:diagnostic imaging* / Q000473:pathology; D018281:Cholangiocarcinoma / Q000000981:diagnostic imaging* / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D003131:Combined Modality Therapy; D003951:Diagnostic Errors; D004621:Embolization, Therapeutic / Q000379:methods; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D006498:Hepatectomy; D006801:Humans; D064847:Multimodal Imaging / Q000379:methods*; D009367:Neoplasm Staging / Q000379:methods*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D016896:Treatment Outcome; D051598:Whole Body Imaging / Q000379:methods; D015021:Yttrium Radioisotopes / Q000627:therapeutic use
chemical_list: D005462:Fluorine Radioisotopes; D019275:Radiopharmaceuticals; D015021:Yttrium Radioisotopes; D019788:Fluorodeoxyglucose F18